Novartis AG (NVS)’in fiyatı nedir?

Novartis AG (NVS)’in fiyatı $148.18’dir

Novartis AG (NVS)’in piyasa değeri nedir?

Novartis AG (NVS)’in piyasa değeri $286.44B’dir.

Novartis AG (NVS) Temettüler

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Yıl	Temettü (hisse bölünmesiyle ayarlanmış)	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü (hisse bölünmesiyle ayarlanmış)

Değiştir

Sağlanan tarihler için yeterli veri yok.

Yıl	Temettü	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Temettü ödemesi sayısı	Ülke
Eli Lilly LLY.US	215.00%	US
AstraZeneca PLC AZN.US	67.00%	GB
Johnson & Johnson JNJ.US	225.00%	US
AbbVie Inc. ABBV.US	53.00%	US
Merck & Co., Inc. MRK.US	223.00%	US

Şirket

Temettü ödemesi sayısı

Ülke